People: Agile Therapeutics Inc (AGRX.OQ)
14 Jun 2019
Ms.Elizabeth Garner, M.D., is Senior Vice President, Chief Medical Officer of Agile Therapeutics, Inc. Previously, she served as Vice President, Medical Affairs, Women's Health and Preventive Care at Myriad Genetics Laboratories from 2012 to 2014. From 2011 to 2012, she was Senior Medical Director, Women's Health at Abbott Laboratories where she served as the Clinical Lead, Endometriosis Program. Prior to that, Dr. Garner served as Associate Director and then Director, Vaccines Clinical Research at Merck Research Laboratories from 2007 to 2011. Dr. Garner received joint M.D. and M.P.H degrees from Harvard Medical School and the School of Public Health. She completed her residency in obstetrics and gynecology at Brigham and Women's/Massachusetts General Hospitals; her subspecialty fellowship in gynecologic oncology at Brigham and Women's and the Dana Farber Cancer Institute; and received board certification in both general Obstetrics and Gynecology and Gynecologic Oncology. Prior to entering the pharmaceutical industry, she had several years of experience in academic clinical practice, research and teaching at Harvard Medical School.
|Total Annual Compensation, USD||369,500|
|Restricted Stock Award, USD||79,100|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||270,997|
|Fiscal Year Total, USD||719,597|